Overview
- IndustryMedicinal Chemicals & Botanical Products1
- HeadquartersLakewood, Colorado1
- Business address200 Union St., Suite 200, Lakewood, Co 802282
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
(“Holdings”), a Delaware limited liability company. On October 10, 2014, we changed our stock symbol from BIMI to AMMJ.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue58¢$1.4M
- Other costs37¢$928.3K
- Interest5¢$113.6K
Out of $2.5M in revenue.4 The company lost money this year.
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.4M5 | $982.3K6 | $2.1M7 | $1.6M8 | $2.4M9 | $18.8M4 | $2.5M4 |
| Cost of revenue | $805.8K5 | $523.8K6 | $791.8K7 | $849.1K8 | $1.4M9 | $16.3M4 | $1.4M4 |
| Gross profit | $1.6M5 | $458.5K6 | $1.3M7 | $720.7K8 | $1.1M9 | $2.5M4 | $10.1M4 |
| Research and development | $2.4K5 | $5906 | $3476 | ||||
| Operating expenses | $2.7M9 | $3.1M4 | $4.9M4 | ||||
| Operating income | -$1.0M6 | -$333.9K7 | -$624.0K8 | -$1.6M9 | -$605.7K4 | -$3.9M4 | |
| Interest | $1.8K8 | $75.4K9 | $78.1K4 | $113.6K4 | |||
| Income tax | |||||||
| Net income | -$1.5M10 | -$950.7K6 | -$301.7K7 | -$532.4K8 | -$1.4M9 | -$633.2K4 | -$3.7M4 |
| Earnings per share | |||||||
| Earnings per share (diluted) |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $1.6M6 | $1.1M7 | $945.2K8 | $1.7M8 | $670.4K9 | $117.5K4 | $21.1K4 |
| Inventory | $278.6K9 | $353.0K4 | $586.2K4 | ||||
| Current assets | $1.8M5 | $1.3M6 | $1.2M7 | $1.9M8 | $1.0M9 | $1.0M4 | $900.4K4 |
| Property, plant and equipment | $375.8K9 | $427.7K4 | $410.3K4 | ||||
| Goodwill | $2.0M9 | $1.3M4 | |||||
| Intangible assets | $745.9K9 | $1.3M9 | $1.0M4 | ||||
| Total assets | $1.9M5 | $1.3M6 | $1.2M7 | $1.9M8 | $4.2M9 | $4.6M4 | $2.8M4 |
| Accounts payable | $242.7K9 | $679.2K4 | $1.0M4 | ||||
| Current liabilities | $1.1M5 | $270.0K6 | $324.4K7 | $261.2K8 | $1.9M9 | $2.1M4 | $2.2M4 |
| Long-term liabilities | $175.0K9 | $613.0K4 | $660.0K4 | ||||
| Total liabilities | $261.2K8 | $2.1M9 | $2.7M4 | $2.8M4 | |||
| Retained earnings | -$9.4M9 | -$10.1M4 | -$13.7M4 | ||||
| Shareholders’ equity | $1.0M7 | $1.0M7 | $879.6K8 | $1.6M9 | $2.1M9 | $1.9M4 | $1.6K4 |
| Shares outstanding | 51.2M shares13 | 52.0M shares5 | 53.5M shares6 | 81.9M shares9 | 92.2M shares4 | 171.4M shares4 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash from operations | $180.5K5 | -$561.5K6 | -$102.8K7 | -$525.8K8 | -$958.0K9 | -$199.0K4 | -$43.0K4 |
| Depreciation and amortization | $42.6K14 | ||||||
| Stock-based compensation | $42.2K9 | $266.2K4 | $1.7M4 | ||||
| Capital spending | $2.2K8 | $357.8K9 | $103.7K4 | $39.1K4 | |||
| Free cash flow | -$528.0K | -$1.3M | -$302.6K | -$82.1K | |||
| Cash from investing | -$1.5M9 | -$103.7K4 | -$39.1K4 | ||||
| Cash from financing | $1.4M9 | -$250.2K4 | $14.6K4 |
Compare American Cannabis Company, Inc. with another company
What it owns
What American Cannabis Company, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $580.4K4 Dec 31, 2023 | $541.3K4 Dec 31, 2022 | +7.2% |
| Accumulated depreciation | $170.1K4 Dec 31, 2023 | $113.7K4 Dec 31, 2022 | +49.7% |
| Property and equipment, net | $410.3K4 Dec 31, 2023 | $427.7K4 Dec 31, 2022 | −4.1% |
| Operating-lease assets (leased space) | $474.5K4 Dec 31, 2023 | $604.0K4 Dec 31, 2022 | −21.4% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $21.1K4 Dec 31, 2023 | $117.5K4 Dec 31, 2022 | −82.1% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Finite-lived intangibles, gross | $1.5M4 Dec 31, 2023 | $1.5M9 Dec 31, 2022 | −0.7% |
| Accumulated amortization | $440.6K4 Dec 31, 2023 | $255.2K9 Dec 31, 2022 | +72.6% |
| Finite-lived intangibles, net | $1.0M4 Dec 31, 2023 | $1.2M4 Dec 31, 2022 | −15.2% |
Inventory
Leadership
Who has led American Cannabis Company, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerEllis Lamar Smith Feb 9, 2022 to Aug 29, 202315
- Chief executive officerTerry Lynn Buffalo Feb 13, 2018 to Feb 13, 201816
- Chief executive officerCorey James Ariel Hollister Oct 14, 2014 to Nov 8, 201617
- Chief executive officerThemistocles Psomiadis Mar 29, 2013 to Mar 29, 201318
- PresidentEllis Lamar Smith Nov 9, 2021 to Jan 20, 202219
- PresidentCorey James Ariel Hollister Oct 26, 2016 to Nov 8, 201620
- Chief financial officerMichael Schwanbeck Feb 26, 2019 to Feb 26, 201921
- Chief financial officerJesus Quintero Jan 13, 2017 to Jan 13, 201722
Board members and other officers (12)
- Principal Executive OfficerTerry Lynn Buffalo Feb 6, 2019 to Feb 6, 202023
- Chief Operations OfficerTyler A. Schloesser Feb 19, 2019 to Aug 29, 202324
- Chief Technology OfficerAnthony J. Baroud Oct 14, 2014 to Oct 14, 201425
- Cheif Development OfficerEllis Lamar Smith Oct 14, 2014 to Jun 2, 202126
- Board memberTerry Lynn Buffalo Feb 13, 2018 to Feb 9, 202216
- Board memberTad M. Mailander Sep 11, 2018 to Aug 29, 202327
- Board memberAnthony J. Baroud Oct 14, 2014 to Oct 14, 201425
- Board memberCorey James Ariel Hollister Oct 14, 2014 to Apr 24, 201717
- Board memberEllis Lamar Smith Oct 14, 2014 to Aug 29, 202326
- Board memberThemistocles Psomiadis Mar 29, 2013 to Sep 2, 201418
- Board memberDouglas Leighton May 16, 2008 to Jul 23, 201428
- Board memberMichael A. Novielli May 30, 2008 to Aug 14, 201429
Former names
Timeline
- May 11, 20268-K Executive or director change30
- May 11, 20268-K Executive or director change31
- Dec 29, 20258-K Executive or director change32
- Jun 18, 20258-K Entered a material agreement33
- Mar 14, 20258-K Ended a material agreement; Executive or director change34
- Mar 5, 20258-K Executive or director change35
- Mar 4, 20258-K Executive or director change36
- Nov 21, 20248-K Entered a material agreement; Executive or director change37
- Nov 8, 20248-K Entered a material agreement; Executive or director change38
- Oct 9, 20248-K Executive or director change39
- Mar 1, 20248-K Entered a material agreement40
- Dec 1, 20238-K Entered a material agreement41
- Feb 9, 2022New chief executive Ellis Lamar Smith becomes CEO15
- Feb 13, 2018New chief executive Terry Lynn Buffalo becomes CEO16
- Oct 14, 2014New chief executive Corey James Ariel Hollister becomes CEO17
- Mar 29, 2013New chief executive Themistocles Psomiadis becomes CEO18
Filings
68 filings to the SEC since October 2021: 4 annual reports, 9 quarterly reports, 24 major events, 20 insider forms, 11 other. The latest 20:
- May 11, 20268-K EDGAR
- May 11, 20268-K EDGAR
- Dec 29, 20258-K EDGAR
- Jun 18, 20258-K EDGAR
- Mar 14, 20258-K EDGAR
- Mar 5, 20258-K EDGAR
- Mar 4, 20258-K EDGAR
- Feb 11, 202510-Q EDGAR
- Nov 21, 20248-K/A EDGAR
- Nov 14, 2024NT 10-Q EDGAR
- Nov 8, 20248-K EDGAR
- Oct 9, 20248-K EDGAR
- Aug 14, 2024NT 10-Q EDGAR
- Jul 15, 202410-Q EDGAR
- May 15, 2024NT 10-Q EDGAR
- May 8, 202410-K EDGAR
- Apr 1, 2024NT 10-K EDGAR
- Mar 1, 20248-K EDGAR
- Dec 1, 20238-K EDGAR
- Nov 14, 202310-Q EDGAR
The 68 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
8 open-market trades by officers, directors and large owners since October 2021: 0 buys and 8 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2023 | Schloesser Tyler AChief Operations Officer | Sale | 1,500,000 | $0.02 | $30.0K | Form 4 |
| Nov 17, 2021 | Smith Ellis LamarChief Executive Officer | Sale | 20,000 | $0.10 | $2.0K | Form 4 |
| Nov 15, 2021 | Smith Ellis LamarChief Executive Officer | Sale | 45,000 | $0.10 | $4.5K | Form 4 |
| Nov 12, 2021 | Smith Ellis LamarChief Executive Officer | Sale | 50,000 | $0.10 | $5.0K | Form 4 |
| Nov 11, 2021 | Smith Ellis LamarChief Executive Officer | Sale | 47,200 | $0.10 | $4.7K | Form 4 |
| Nov 10, 2021 | Smith Ellis LamarChief Executive Officer | Sale | 57,800 | $0.10 | $5.8K | Form 4 |
| Nov 9, 2021 | Smith Ellis LamarChief Executive Officer | Sale | 33,891 | $0.10 | $3.4K | Form 4 |
| Nov 8, 2021 | Smith Ellis LamarChief Executive Officer | Sale | 91,109 | $0.10 | $9.5K | Form 4 |
From Forms 4 filed with the SEC.
SEC filer profile
How American Cannabis Company, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAmerican Cannabis Company, Inc.1
- CIK0000945617
- Employer ID (EIN)90-11166251
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Fiscal year endsDecember 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address200 Union St., Suite 200, Lakewood, CO 802281
- Phone303-974-47701
- Shares outstanding185,800,915 as of Feb 11, 202512
- Public float$1.7M as of Dec 31, 20234
- On EDGAR sinceMay 14, 19961
- Filings560 in all: 4 (121), 8-K (89), 10-Q (49), NT 10-Q (47), 10QSB (35), NT 10-K (25), 4/A (22), 10-K (18)1
All 43 form types
5 (14), 8-K/A (14), UPLOAD (14), 3 (13), 10KSB (12), 10-Q/A (9), SC 13D (9), 10QSB/A (8), PRER14C (6), 10KSB/A (5), CORRESP (5), S-8 (5), PRE 14C (4), 424B3 (3), DEF 14C (3), NTN 10K (3), SC 13D/A (3), 10-K/A (2), EFFECT (2), PRE 14A (2), REGDEX (2), S-1 (2), S-1/A (2), 15-12G (1), 15-12G/A (1), 3/A (1), D (1), DEF 14A (1), PRER14A (1), REGDEX/A (1), S-8 POS (1), SB-2 (1), SB-2/A (1), SC 13G (1), SC 14F1 (1)
- Latest filingsAnnual report (10-K) May 8, 2024
Quarterly report (10-Q) Feb 11, 2025
Proxy statement (DEF 14A) May 16, 2000
Latest 8-K (8-K) May 11, 2026
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19SEC EDGAREllis Lamar Smith, President
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27SEC EDGARTad M. Mailander, Board member
- 28SEC EDGARDouglas Leighton, Board member
- 29SEC EDGARMichael A. Novielli, Board member
- 30SEC EDGARExecutive or director change
- 31SEC EDGARExecutive or director change
- 32SEC EDGARExecutive or director change
- 33SEC EDGAREntered a material agreement
- 34
- 35SEC EDGARExecutive or director change
- 36SEC EDGARExecutive or director change
- 37
- 38
- 39SEC EDGARExecutive or director change
- 40SEC EDGAREntered a material agreement
- 41SEC EDGAREntered a material agreement